Mark Astill News Today : Breaking News, Live Updates & Top Stories | Vimarsana

May 03, 2021 10:00 AM The University of Utah (the U), ARUP Laboratories, and Techcyte Inc. have formed a partnership to develop NanoSpot.AI, a fast, easy-to-administer SARS-CoV-2 antibody test. The University of Utah (the U), ARUP Laboratories, and Techcyte Inc. announced today that they have formed a partnership to develop NanoSpot.AI, a less than five-minute, easy-to-administer SARS-CoV-2 antibody test. NanoSpot.AI is estimated to be significantly less expensive to manufacture than other SARS-CoV-2 antibody tests, so it has the potential to be considerably more affordable than currently av...

The patent-pending NanoSpot.AI is performed on a spot of blood obtained through a finger prick, and individuals receive test results on their mobile phones. The test is estimated to be significantly less expensive to manufacture than other SARS-CoV-2 antibody tests, so it has the potential to be considerably more affordable than currently available tests, making it possible to extend the test to every corner of the world. Clinical studies validating NanoSpot.AI are currently underway.